Search Results 361-370 of 17945 for lupus

  1. Alexander R. Shusko, Jr., M.D. - Doctors and Medical Staff - Mayo Clinic

    Procedures performed · Cataract surgery · Interests. Uveitis; Birdshot Chorioretinopathy; Coccidioidomycosis; Toxoplasmosis; Sarcoidosis; Systemic lupus ...

  2. Esomeprazole (intravenous route) - Side effects & uses - Mayo Clinic

    Cutaneous or systemic lupus erythematosus may occur or get worse in lupus patients receiving a PPI. Call your doctor right away if you or your child have ...

  3. Systemic mastocytosis - Symptoms and causes - Mayo Clinic

    Excess mast cells can build up in skin, bone and organs. When triggered, the cells release substances that can cause allergic reactions and organ damage.

  4. Granuloma annulare - Symptoms and causes - Mayo Clinic

    Learn about this painless skin condition mainly affecting young adults in which bumps form a ring. The rash can be long lasting or recur after treatment.

  5. Faculty and Staff - Rheumatology - Mayo Clinic Research

    Rheumatology. Sections. Overview · Faculty and Staff · Focus Areas · Lupus and New Glucocorticoid Strategies · Contact. Faculty and Staff. Sort by. Abril, Andy ...

  6. Dermatology - Doctors - Mayo Clinic

    Elisha Singer, M.D.. Dermatologist. Jacksonville, FL. Areas of focus: Skin biopsy, Cryotherapy, Electrodessication and curettage, Steroid injection, Lupus, ...

  7. Dextromethorphan and quinidine (oral route) - Side effects & dosage - Mayo Clinic

    Lupus-like syndrome caused by quinidine, quinine, or mefloquine, history of or; Thrombocytopenia (low platelets in the blood) caused by quinidine, quinine ...

  8. Meet Our Fellows - Rheumatology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    Georges El Hasbani, M.D.. Clinical Interests: Systemic lupus erythematosus, antiphospholipid syndrome, and rare autoinflammatory diseases. Research Interests: ...

  9. Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Patients Who Participated in ADDRESS II) - Mayo Clinic

    ... lupus erythematosus (SLE). The Week 24 visit of ADDRESS II core trial will coincide with the Day 1 visit of this LTE trial. Participation eligibility.

  10. Nephrology and Hypertension - Conditions treated - Mayo Clinic

    Lupus nephritis; Malignant hypertension; Membranous nephropathy; Microscopic polyangiitis; Minimal change disease; Monoclonal gammopathy of undetermined ...